125 related articles for article (PubMed ID: 20060545)
21. Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke.
Schulze F; Carter AM; Schwedhelm E; Ajjan R; Maas R; von Holten RA; Atzler D; Grant PJ; Böger RH
Atherosclerosis; 2010 Feb; 208(2):518-23. PubMed ID: 19700158
[TBL] [Abstract][Full Text] [Related]
22. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
Selley ML
J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
[TBL] [Abstract][Full Text] [Related]
23. Increased serum asymmetric dimethylarginine levels in primary dysmenorrhea.
Akdemir N; Cinemre H; Bilir C; Akin O; Akdemir R
Gynecol Obstet Invest; 2010; 69(3):153-6. PubMed ID: 19996604
[TBL] [Abstract][Full Text] [Related]
24. Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow.
Selcuk MT; Selcuk H; Temizhan A; Maden O; Ulupinar H; Baysal E; Ozeke O; Sasmaz A
Coron Artery Dis; 2007 Nov; 18(7):545-51. PubMed ID: 17925608
[TBL] [Abstract][Full Text] [Related]
25. Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment.
Bae SW; Stühlinger MC; Yoo HS; Yu KH; Park HK; Choi BY; Lee YS; Pachinger O; Choi YH; Lee SH; Park JE
Am J Cardiol; 2005 Mar; 95(6):729-33. PubMed ID: 15757598
[TBL] [Abstract][Full Text] [Related]
26. [Changes of serum asymmetric dimethylarginine in essential hypertension before and after the treatment].
Zhang WR; Chen BM; Xiong Y; Tao LJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 30(1):57-9. PubMed ID: 15871189
[TBL] [Abstract][Full Text] [Related]
27. Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure.
Nanayakkara PW; Teerlink T; Stehouwer CD; Allajar D; Spijkerman A; Schalkwijk C; ter Wee PM; van Guldener C
Kidney Int; 2005 Nov; 68(5):2230-6. PubMed ID: 16221223
[TBL] [Abstract][Full Text] [Related]
28. Increased levels of asymmetric dimethylarginine (ADMA) in patients with ankylosing spondylitis.
Sari I; Kebapcilar L; Alacacioglu A; Bilgir O; Yildiz Y; Taylan A; Yuksel A; Kozaci DL
Intern Med; 2009; 48(16):1363-8. PubMed ID: 19687580
[TBL] [Abstract][Full Text] [Related]
29. Asymmetric dimethylarginine (ADMA) has a role in regulating systemic vascular tone in young healthy subjects: the cardiovascular risk in young Finns study.
Päivä H; Kähönen M; Lehtimäki T; Raitakari OT; Jula A; Viikari J; Alfthan G; Juonala M; Laaksonen R; Hutri-Kähönen N
Am J Hypertens; 2008 Aug; 21(8):873-8. PubMed ID: 18551100
[TBL] [Abstract][Full Text] [Related]
30. Asymmetric dimethylarginine, cortisol/cortisone ratio, and C-peptide: markers for diabetes and cardiovascular risk?
Anderson JL; Carlquist JF; Roberts WL; Horne BD; May HT; Schwarz EL; Pasquali M; Nielson R; Kushnir MM; Rockwood AL; Bair TL; Muhlestein JB;
Am Heart J; 2007 Jan; 153(1):67-73. PubMed ID: 17174641
[TBL] [Abstract][Full Text] [Related]
31. Association between plasma asymmetrical dimethylarginine activity and saphenous vein graft disease in patients with coronary bypass.
Cagirci G; Cay S; Karakurt O; Buyukterzi Z; Yazihan N; Kilic H; Topaloglu S; Aras D; Akdemir R
Coron Artery Dis; 2010 Jan; 21(1):20-5. PubMed ID: 19996737
[TBL] [Abstract][Full Text] [Related]
32. Effects of eicosapentaenoic acid on asymmetric dimethylarginine in patients in the chronic phase of cerebral infarction: a preliminary study.
Hagiwara H; Nishiyama Y; Katayama Y
J Stroke Cerebrovasc Dis; 2011; 20(5):474-8. PubMed ID: 21277225
[TBL] [Abstract][Full Text] [Related]
33. Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidaemia in adolescent girls with polycystic ovary syndrome.
Demirel F; Bideci A; Cinaz P; Camurdan MO; Biberoğlu G; Yesilkaya E; Hasanoğlu A
Clin Endocrinol (Oxf); 2007 Jul; 67(1):129-34. PubMed ID: 17465999
[TBL] [Abstract][Full Text] [Related]
34. Correlation of the L-Arginine Pathway with Thrombo-Inflammation May Contribute to the Outcome of Acute Ischemic Stroke.
Molnar T; Pusch G; Nagy L; Keki S; Berki T; Illes Z
J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):2055-60. PubMed ID: 27263035
[TBL] [Abstract][Full Text] [Related]
35. Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension.
Curgunlu A; Uzun H; Bavunoğlu I; Karter Y; Genç H; Vehid S
J Hum Hypertens; 2005 Aug; 19(8):629-33. PubMed ID: 15829997
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of asymmetric dimethylarginine and homocysteine in microangiopathy-related cerebral damage.
Notsu Y; Nabika T; Bokura H; Suyama Y; Kobayashi S; Yamaguchi S; Masuda J
Am J Hypertens; 2009 Mar; 22(3):257-62. PubMed ID: 19057516
[TBL] [Abstract][Full Text] [Related]
37. Endogenous nitric oxide synthase inhibitors, arterial hemodynamics, and subclinical vascular disease: the PREVENCION Study.
Chirinos JA; David R; Bralley JA; Zea-Díaz H; Muñoz-Atahualpa E; Corrales-Medina F; Cuba-Bustinza C; Chirinos-Pacheco J; Medina-Lezama J
Hypertension; 2008 Dec; 52(6):1051-9. PubMed ID: 18852383
[TBL] [Abstract][Full Text] [Related]
38. Determination of a reference value for N(G), N(G)-dimethyl-L-arginine in 500 subjects.
Schulze F; Maas R; Freese R; Schwedhelm E; Silberhorn E; Böger RH
Eur J Clin Invest; 2005 Oct; 35(10):622-6. PubMed ID: 16178881
[TBL] [Abstract][Full Text] [Related]
39. Subtle changes in ADMA and l-arginine concentrations in normal pregnancies are unlikely to account for pregnancy-related increased flow-mediated dilatation.
Saarelainen H; Valtonen P; Punnonen K; Laitinen T; Raitakari OT; Juonala M; Heiskanen N; Lyyra-Laitinen T; Viikari JS; Vanninen E; Heinonen S
Clin Physiol Funct Imaging; 2008 Mar; 28(2):120-4. PubMed ID: 18093231
[TBL] [Abstract][Full Text] [Related]
40. Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients.
Pasini AF; Garbin U; Stranieri C; Boccioletti V; Mozzini C; Manfro S; Pasini A; Cominacini M; Cominacini L
Am J Hypertens; 2008 Nov; 21(11):1251-7. PubMed ID: 18772860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
